NFKB1 and hepatocellular carcinoma: Zhou et al. (2019) showed that SIRT‐1 suppressed hepatocellular carcinoma cell line growth and metastasis via activating the NF‐κB pathway and promoting M1 macrophage polarization (Zhou et al., 2019).